21-33432659-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000420455.5(TMEM50B):​n.*2264A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.73 in 1,579,122 control chromosomes in the GnomAD database, including 424,203 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.77 ( 45996 hom., cov: 31)
Exomes 𝑓: 0.73 ( 378207 hom. )

Consequence

TMEM50B
ENST00000420455.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.43

Publications

21 publications found
Variant links:
Genes affected
TMEM50B (HGNC:1280): (transmembrane protein 50B) Predicted to be involved in late endosome to vacuole transport via multivesicular body sorting pathway. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]
IFNGR2 (HGNC:5440): (interferon gamma receptor 2) This gene (IFNGR2) encodes the non-ligand-binding beta chain of the gamma interferon receptor. Human interferon-gamma receptor is a heterodimer of IFNGR1 and IFNGR2. Defects in IFNGR2 are a cause of mendelian susceptibility to mycobacterial disease (MSMD), also known as familial disseminated atypical mycobacterial infection. MSMD is a genetically heterogeneous disease with autosomal recessive, autosomal dominant or X-linked inheritance. [provided by RefSeq, Jul 2008]
IFNGR2 Gene-Disease associations (from GenCC):
  • immunodeficiency 28
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 21-33432659-T-C is Benign according to our data. Variant chr21-33432659-T-C is described in ClinVar as Benign. ClinVar VariationId is 1268638.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.961 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000420455.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IFNGR2
NM_005534.4
MANE Select
c.722-55T>C
intron
N/ANP_005525.2
TMEM50B
NR_040016.2
n.2919A>G
non_coding_transcript_exon
Exon 9 of 9
IFNGR2
NM_001329128.2
c.779-55T>C
intron
N/ANP_001316057.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TMEM50B
ENST00000420455.5
TSL:1
n.*2264A>G
non_coding_transcript_exon
Exon 9 of 9ENSP00000397773.1
TMEM50B
ENST00000420455.5
TSL:1
n.*2264A>G
3_prime_UTR
Exon 9 of 9ENSP00000397773.1
IFNGR2
ENST00000290219.11
TSL:1 MANE Select
c.722-55T>C
intron
N/AENSP00000290219.5

Frequencies

GnomAD3 genomes
AF:
0.773
AC:
117515
AN:
152032
Hom.:
45937
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.865
Gnomad AMI
AF:
0.636
Gnomad AMR
AF:
0.813
Gnomad ASJ
AF:
0.644
Gnomad EAS
AF:
0.984
Gnomad SAS
AF:
0.776
Gnomad FIN
AF:
0.794
Gnomad MID
AF:
0.687
Gnomad NFE
AF:
0.698
Gnomad OTH
AF:
0.743
GnomAD4 exome
AF:
0.725
AC:
1034793
AN:
1426972
Hom.:
378207
Cov.:
25
AF XY:
0.724
AC XY:
515612
AN XY:
712186
show subpopulations
African (AFR)
AF:
0.870
AC:
28512
AN:
32768
American (AMR)
AF:
0.852
AC:
38092
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.645
AC:
16689
AN:
25880
East Asian (EAS)
AF:
0.976
AC:
38599
AN:
39530
South Asian (SAS)
AF:
0.765
AC:
65474
AN:
85586
European-Finnish (FIN)
AF:
0.788
AC:
41942
AN:
53256
Middle Eastern (MID)
AF:
0.682
AC:
3893
AN:
5708
European-Non Finnish (NFE)
AF:
0.702
AC:
757915
AN:
1080212
Other (OTH)
AF:
0.736
AC:
43677
AN:
59340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
14912
29825
44737
59650
74562
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19074
38148
57222
76296
95370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.773
AC:
117631
AN:
152150
Hom.:
45996
Cov.:
31
AF XY:
0.780
AC XY:
58008
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.866
AC:
35958
AN:
41538
American (AMR)
AF:
0.814
AC:
12426
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.644
AC:
2234
AN:
3468
East Asian (EAS)
AF:
0.984
AC:
5085
AN:
5170
South Asian (SAS)
AF:
0.776
AC:
3745
AN:
4828
European-Finnish (FIN)
AF:
0.794
AC:
8406
AN:
10582
Middle Eastern (MID)
AF:
0.694
AC:
204
AN:
294
European-Non Finnish (NFE)
AF:
0.698
AC:
47421
AN:
67978
Other (OTH)
AF:
0.744
AC:
1572
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1333
2667
4000
5334
6667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
856
1712
2568
3424
4280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.719
Hom.:
19868
Bravo
AF:
0.781
Asia WGS
AF:
0.890
AC:
3096
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 92% of patients studied by a panel of primary immunodeficiencies. Number of patients: 81. Only high quality variants are reported.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.37
DANN
Benign
0.36
PhyloP100
-1.4
PromoterAI
0.071
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1532; hg19: chr21-34804966; API